Longboard Pharmaceuticals Current Cash

Longboard Pharmaceuticals (LBPH) currently reports a current cash of $28M as of September 2024. That compares with $24M in the prior-year period — up 15.5% year over year. Use the charts on this page to explore Longboard Pharmaceuticals's current cash history and peer comparisons.

Longboard Pharmaceuticals's current cash increased from $24M to $28M — a 15.5% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Longboard Pharmaceuticals reported $28M in current cash as of September 2024. That compares with $24M in the prior-year period — up 15.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $28M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Longboard Pharmaceuticals, and consider following LBPH for alerts when major investors trade the stock.

Longboard Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $28M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBPH with unrelated industries.